Into the era of mycobiome-driven cancer research.

IF 14.3 1区医学 Q1 ONCOLOGY

Trends in cancer Pub Date : 2024-05-01 Epub Date: 2024-03-16 DOI:10.1016/j.trecan.2024.02.009

Weici Liu, Zheshun Pi, Ning-Ning Liu, Wenjun Mao

引用次数: 0

Abstract

The cancer mycobiome has recently become a research hotspot. While the intratumor mycobiota is implicated in cancer initiation and progression, the gut mycobiota functions as biomarkers for cancer diagnosis and treatment. In this forum article we highlight the involvement of the mycobiome in correlation-, causation-, and prediction-oriented cancer research and discuss the potential of this burgeoning field.

查看原文本刊更多论文

进入霉菌生物群驱动的癌症研究时代。

癌症真菌生物群最近成为研究热点。肿瘤内的霉菌生物群与癌症的发生和发展有关，而肠道霉菌生物群则是癌症诊断和治疗的生物标志物。在这篇论坛文章中，我们将重点介绍霉菌生物群在以相关性、因果性和预测性为导向的癌症研究中的参与情况，并讨论这一新兴领域的潜力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Trends in cancer Medicine-Oncology

CiteScore

28.50

自引率

0.50%

发文量

138

期刊介绍： Trends in Cancer, a part of the Trends review journals, delivers concise and engaging expert commentary on key research topics and cutting-edge advances in cancer discovery and medicine. Trends in Cancer serves as a unique platform for multidisciplinary information, fostering discussion and education for scientists, clinicians, policy makers, and patients & advocates.Covering various aspects, it presents opportunities, challenges, and impacts of basic, translational, and clinical findings, industry R&D, technology, innovation, ethics, and cancer policy and funding in an authoritative yet reader-friendly format.